Are Vertex Secur. latest results good or bad?
Vertex Securities' latest financial results are concerning, showing a significant decline in key metrics, including a profit before tax of Rs -0.81 crore and a year-on-year net sales drop of 52.96%, indicating ongoing operational challenges.
Vertex Securities has reported its financial results for the quarter ending March 2025, revealing a significant downturn in key performance metrics. The company's profit before tax less other income (PBT) was recorded at Rs -0.81 crore, which represents a year-on-year decline of 235%, marking the lowest PBT in the last five quarters. This decline indicates a concerning trend in the company's financial health.Additionally, the operating profit (PBDIT) also fell to Rs -0.66 crore, the lowest point in the same five-quarter timeframe, highlighting ongoing challenges in operational performance. The earnings per share (EPS) similarly reflected a downturn, with the latest figure at Rs -0.07, again the lowest in five quarters, suggesting reduced profitability and earnings for shareholders.
The net sales for the quarter showed a year-on-year growth of -52.96%, a stark contrast to the previous year's growth of 111.03%. Furthermore, the consolidated net profit exhibited a year-on-year growth of -178.26%, compared to a positive growth of 216.95% in the prior year.
Overall, Vertex Securities has faced a notable decline in its financial performance, leading to an adjustment in its evaluation over the past three months. The data indicates a challenging operational environment for the company, as evidenced by the significant drops across various financial metrics.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
